Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency

NCT07551804 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xiamen Amoytop Biotech Co., Ltd.